EDGAR Filing Documents for 0001193125-15-254408

Form 8-K - Current report:

SEC Accession No. 0001193125-15-254408

Filing Date

2015-07-16

Accepted

2015-07-16 09:00:52

Documents

Period of Report

2015-07-13

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d55409d8k.htm	8-K	23429
2	EX-99.1	d55409dex991.htm	EX-99.1	55114
3	EX-99.2	d55409dex992.htm	EX-99.2	10167
4	GRAPHIC	g55409ex99_2pg01.jpg	GRAPHIC	10784
	Complete submission text file	0001193125-15-254408.txt		105298

Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628

Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020

ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)